• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AJMC® in the Press, September 30, 2022

Article

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

An article by HealthLeaders cited a study published in the September 2022 issue of The American Journal of Managed Care® (AJMC®). In the study, “Insurers Negotiate Lower Hospital Prices for HIX Than for Commercial Groups,” hospital price transparency data suggested that health insurance exchange plans get lower negotiated rates than commercial group plans and higher negotiated rates than Medicare Advantage plans.

Another piece by HealthLeaders spotlighted an article published on AJMC.com, the website of AJMC®. The article covered recent daily news updates, including how nonprofit hospitals pursue profits from low-income patients and an announcement by the Biden administration that $1.5 billion would be set aside to battle opioid overdoses and support recovery.

An article by Digital Health referenced a 2020 study published in a supplement to AJMC®, titled “Economic Burden of Alzheimer Disease and Managed Care Considerations.” The study indicated that health care costs associated with the treatment of Alzheimer disease were an estimated $305 billion in 2020.

Related Videos
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Pierluigi Porcu, MD
Image credit: Medical technology and futuristic concept. Doctor hologram modern virtual screen interface | SOMKID - stock.adobe.com
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Elizabeth Grush, MBA
Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center
Erin Weber, MS
Kenny Cole, MD
Joseph Saseen, PharmD
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.